Immunomodulatory properties of antiviral acyclic nucleotide analogues: Cytokine stimulatory and nitric oxide costimulatory effects

International Journal of Immunopharmacology

Volumn 19, Issue 9-10, 1997, Pages 587-597

  Zídek, Zdeněk ^a   Holý, Antonín ^b   Franková, Daniela ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b INSTITUTE OF ORGANIC CHEMISTRY AND BIOCHEMISTRY   (Czech Republic)

Author keywords

Acyclic nucleotide analogues; Antiviral agents; Interleukin 10; Nitric oxide; Tumour necrosis factor

Indexed keywords

2,6 DIAMINO 9 (2 PHOSPHONOMETHOXYETHYL)PURINE; 9 [2 (PHOSPHONOMETHOXY)ETHYL]GUANINE; 9 [2 (PHOSPHONOMETHOXY)PROPYL] 2,6 DIAMINOPURINE; ADEFOVIR; ANTIVIRUS AGENT; CIDOFOVIR; TENOFOVIR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DRUG EFFECT; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIVIRAL AGENTS; CYTOKINES; FEMALE; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-10; MACROPHAGES, PERITONEAL; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NUCLEOTIDES; ORGANOPHOSPHORUS COMPOUNDS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 18144452428     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(97)00047-7     Document Type: Conference Paper

References (55)

1. Akarid, K., Sinet, M., Desforges, B. & Gougerot-Pocidalo, M. A. (1995) Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo. J. Virol., 69, 7001-7014.
2. Akridge, R. E., Oyafuso, L. K. & Reed, S. G. (1994) IL-10 is induced during HIV-1 infection and is capable of decreasing viral replication in human macrophages. J. Immunol., 153, 5782-5789.
3. Amber, I. J., Hibbs, J. B. Jr, Taintor, R. R. & Vavrin, Z. (1988) Cytokines induce an L-arginine-dependent effector system in nonmacrophage cells. J. Leukocyte Biol., 44, 58-65.
4. Balzarini, J., Holý, A., Jindřich, J., Naesens, L., Snoeck, R., Schols, D. & De Clercq, E. (1993) Differential antiherpes virus effects of the (S) and (R) enantiomers of acyclic nucleoside phosphonates: potent and selective in vitro and in vivo antiretrovirus activities of (R)-9-(2-phosphonomethoxypropyl)-2,6-diaminopurine. Antimicrob. Agents. Chemother., 37, 332-338.
5. Balzarini, J., Aquaro, S., Perno, C. F., Witvrouw, M., Holý, A. & De Clercq, E. (1996) Activity of the (R)-enantiomers of 9-(2-phosphonylmethoxypropyl)-adenine and 9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine against human immunodeficiency virus in different human cell systems. Biochem. Biophys. Res. Commun., 219, 337-341.
6. Bischofberger, N., Tsai, C. -C., Follis, K. E., Sabo, A., Grant, R. F., Beck, T. W., Dailey, P. J. & Black, R. (1996) Antiviral efficacy of PMPA in macaques chronically infected with SIV. Antiviral Res., 30, 42 (in abstract).
7. Bogdan, C., Röllinghoff, M., Vodovotz, Y., Xie, Q.-wen. & Nathan, C. (1994) Regulation of inducible nitric oxide synthase in macrophages by cytokines and microbial products, In Immunotherapy of Infections (ed. Masihi, K. N.), pp. 37-54. Marcel Dekker, New York..
8. Calio, R., Villani, N., Balestra, E., Sesa, F., Holý, A., Balzarini, J., De Clercq, E., Perno, C. F. & Del Gobbo, V. (1994) Enhancement of natural killer activity and interferon induction by different acyclic nucleotide phosphonates. Antiviral Res., 23, 77-89.
9. Chang, J., Naif, H. M., Li, S., Jozwiak, R., HoShon, M. & Cunningham, A. L. (1996) The inhibition of HIV replication in monocytes by interleukin 10 is linked to inhibition of cell differentiation. AIDS Res. Hum. Retrovirus, 12, 1227-1236.
10. Cherrington, J. M., Allen, S. J. W., Bischofberger, N. & Chen, M. S. (1995) Kinetic interaction of the diphosphates of 9-(2-phosphonylmethoxyethyl)-adenine and other anti-HIV active purine congeners with HIV reverse trancriptase and human DNA polymerases α, β and γ. Antivir. Chem. Chemother., 6, 217-221.
11. Chesrown, S. E., Monnier, J., Visner, G. & Nick, H. S. (1994) Regulation of inducible nitric oxide synthase mRNA levels by LPS, IFN-γ, TGF-β and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem. Biophys. Res. Commun., 200, 126-134.
12. Corradin, S. B., Fasel, N., Buchmüller-Rouiller, Y., Ransijn, A., Smith, J. & Mauël, J. (1993) Induction of macrophage nitric oxide production by interferon-γ and tumor necrosis factor-α is enhanced by interleukin-10. Eur. J. Immunol., 23, 2045-2048.
13. Croen, K. D. (1993) Evidence for an antiviral effect of nitric oxide. Inhibition of herpes simplex virus type 1 replication. J. Clin. Invest., 91, 2446-2452.
14. Cundy, K. C., Barditch-Crovo, P. A., Walker, A. C., Collier, D., Ebeling, D., Toole, J. & Jaffe, H. S. (1995) Clinical pharmacokinetics of Adefovir in human immunodeficiency virus type 1-infected patients. Antimicrob. Agents. Chemother., 39, 2401-2405.
15. De Clercq, E. (1996) Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. Herpes-, papova-, pox- and adenovirus) infections. Verh. K. Acad. Geneeskd. Belg., 58, 19-47.
16. Del Gobbo, V., Foli, A., Balzarini, J., De Clercq, E., Balestra, E., Villani, N., Marini, S., Perno, C. F. & Calio, R. (1991) Immunomodulatory activity of 9-(2-phosphonyl-methoxyethyl)adenine (PMEA), a potent anti-HIV nucleotide analogueue, on in vivo murine models. Antiviral Res., 16, 65-75.
17. Dereuddre-Bosquet, N., Clayette, P., Martin, M., Mabondzo, A., Frétier, P., Gras, G., Martal, J. & Dormont, D. (1996) Anti-HIV potential of a new interferon, interferon-τ (thromboplastin). J. Acquir. Immun. Def. Syndr. Hum. Retrovir., 11, 241-246.
18. Dhawan, S., Heredia, A., Wahl, L. M., Epstein, J. S., Meltzer, M. S. & Hewlett, I. K. (1995) Interferon-gamma-induced downregulation of CD4 inhibits the entry of human immunodeficiency virus type-1 in primary monocytes. Pathobiology, 63, 93-99.
19. Fauci, A. S. (1995) An elusive soluble suppressor. Nature, 378, 561.
20. Gendelman, H. E., Baca, L. M., Turpin, J., Kalrer, D. C., Hansen, B., Orenstein, J. M., Diffenbach, C. W., Friedman, R. M. & Meltzer, M. S. (1990) Regulation of HIV replication in infected monocytes by IFN-α, mechanisms for viral restrictions. J. Immunol., 145, 2669-2676.
21. Gong, Y. -F., Marshall, D. R., Srinivas, R. V. & Fridland, A. (1994) Susceptibilities of zidovudine-resistant variants of human immunodeficiency virus type 1 to inhibition by acyclic nucleoside phosphonates. Antimicrob. Agents. Chemother., 38, 1683-1687.
22. Heijtink, R. A., Kruining, J., de Wilde, G. A., Balzarini, J., De Clercq, E. & Schalm, S. W. (1994) Inhibitory effects of acyclic nucleoside phosphonates on human hepatitis B virus and duck hepatitis B virus infections in tissue culture. Antimicrob. Agents. Chemother., 38, 2180-2182.
23. Ho, H. T. Woods, K. L., Konrad, S. A., De Boeck, H. & Hitchcock, M. J. (1992) Cellular metabolism and enzymatic phosphorylation of 9-(2-phosphonylmethoxyethyl) guanine (PMEG), a potent antiviral agent. Adv. Exp. Med. Biol., 312, 159-166.
24. Holý, A. & Masojidková, M. (1995) Synthesis of enantiomeric 9-(2-phosphonomethoxypropyl) derivatives of purine and pyrimidine bases. 1. Stepwise approach. Collect. Czech. Chem. Commun., 60, 1196-1212.
25. Holý, A., Rosenberg, I. & Dvořáková, H. (1989) Synthesis of 3-hydroxy-2-phosphonylmethoxypropyl)derivatives of heterocyclic bases. Collect. Czech. Chem. Commun., 54, 2470-2501.
26. Holý, A., Votruba, I., Merta, A., Černý, J., Veselý, J., Vlach, J., Šedivá, K., Rosenberg, I., Otmar, M., Hřebabecký, H., Trávníček, M., Vonka, V., Snoeck, R. & De Clercq, E. (1990) Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro. Antiviral. Res., 13, 295-311.
27. Kambayashi, T., Jacob, C. O., Zhou, D., Mazurek, M., Fong, M. & Strassmann, G. (1995) Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-α and IL-6 release by endotoxin-stimulated macrophages. J. Immunol., 155, 4909-4916.
28. Karupiah, G., wen Xie, Q., Buller, R. M. L., Nathan, C., Duarte, C. & MacMicking, J. D. (1993) Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science, 261, 1445-1448.
29. Kootstra, N. A., vant Wout, A. B., Huisman, J. G., Miedema, F. & Schuitemaker, H. (1994) Interference of IL-10 with HIV-1 replication in primary monocyte derived macrophages. J. Virol., 68, 6967-6975.
30. Kramata, P., Votruba, I., Otová, B. & Holý, A. (1996) Different inhibitory potencies of acyclic phosphonomethoxyalkyl nucleotide analogues toward DNA polymerases α, δ and ∈. Mol. Pharmacol., 49, 1005-1011.
31. Kreider, J. W., Balogh, K., Olson, R. O. & Martin, J. C. (1990) Treatment of latent rabbit and human papillomavirus infections with 9-(2-phosphonylmethoxy)ethyl-guanine (PMEG). Antiviral. Res., 14, 51-58.
32. Lalezari, J. P., Drew, W. L., Glutzer, E., James, C., Miner, D., Flaherty, J., Fisher, P. E., Cundy, K., Hannigan, J., Martin, J. C. & Jaffe, H. S. (1995) (S)-1-[3-hydroxy-2-(phosphonytmethoxy)propyl]cytosine (Cidofovir): results of a phase I/II study of a novel antiviral nucleotide analogue. J. infect. Dis., 171, 788-796.
33. Lin, J. C., De Clercq, E. & Pagano, J. S. (1991) Inhibitory effect of acyclic nucleoside phosphonate analogues, including (S)-1-(3-hydroxy-2-phosphonylmethoxy-propyl)cytosine, on Epstein-Barr virus replication. Antimicrob. Agents. Chemother., 35, 2440-2443.
34. Lucin, P., Jonjic, S., Messerle, M., Polic, B., Hengel, H. & Koszinowski, U. H. (1994) Late phase inhibition of murine cytomegalovirus replication by synergistic action of interferon-gamma and tumour necrosis factor. J. Gen. Virol., 75, 101-110.
35. Marletta, M. A., Yoon, P. S., Iyengar, R., Leaf, C. D. & Wishnok, J. S. (1988) Macrophage oxidation of L-arginine to nitrite and nitrate. Biochemistry, 27, 8706-8711.
36. Masood, R., Lunardi-Iskandar, Y., Moudgil, T., Zhang, Y., Law, R. E., Huang, C. L., Puri, R. K., Levine, A. M. & Gill, P. S. (1994) IL-10 inhibits HIV-1 replication and is induced by rat. Biochem. Biophys. Res. Commun., 202, 374-383.
37. Mayer, A., Gelderblom, H., Kumel, G. & Jungwirth, C. (1992) Interferon-gamma-induced assembly bloc in the replication cycle of adenovirus 2: augmentation by tumor necrosis factor-alpha. Virology, 187, 372-376.
38. Meisel, C., Vogt, K., Platzer, C., Randow, F., Liebenthal, C. & Volk, H. -D. (1996) Differential regulation of monocytic tumor necrosis factor-α and interleukin-10 expression. Eur. J. Immunol., 26, 1580-1586.
39. Montaner, L. J., Dozle, A. G., Collin, M., Herbein, G., Illei, P., James, W., Minty, A., Caput, D., Ferrara, P. & Gordon, S. (1993) Interleukin 13 inhibits human immunodeficiency virus type I production in primary blood-derived human macrophages in vitro.. J. exp. Med., 178, 743-747.
40. Naesens, L., Balzarini, J., Holý, A., Rosenberg, I. & De Clercq, E. (1994a) Antiretroviral efficacy of 9-(2-phosphonomethoxyethyl)adenine and of 9-(2-phosphono-methoxyethyl(-2,6-diaminopurine in mice infected with Friend Leukemia virus. In UCLA Symposia on Molecular and Cellular Biology. HIV and AIDS: Pathogenesis, Therapy and Vaccine, Abstract Book, Keystone, CO, U.S.A.
41. Naesens, L., Balzarini, J. & De Clercq, E. (1994b) Therapeutic potential of PMEA as an antiviral drug. Rev. Med. Virol., 4, 147-159.
42. Nathan, C. (1992) Nitric oxide as a secretory product of mammalian cells. FASEB JI, 6, 3051-3064.
43. Perno, C. F., Balestra, S., Aquaro, S., Panti, S., Cenci, A., Lazzarino, G., Tavazzi, B., Dipierro, D., Balzarini, J. & Calio, R. (1996) Potent inhibition of human immunodeficiency virus and herpes simplex virus type 1 by 9-(2-phosphonylmethoxyethyl)adenine in primary macrophages is determined by drug metabolism, nucleotide pools, and cytokines. Mol. Pharmacol., 50, 359-366.
44. Poli, G., Kinter, A. L., Justement, J. S., Bressler, P., Kehrl, J. H. & Fauci, A. S. (1991) Transforming growth factor β suppresses human immunodeficiency virus expression and replication in infected cells of the monocyte/macrophage lineage. J. exp. Med., 173, 589-597.
45. Reymen, D., Naesens, L., Balzarini, J., Holý, A., Dvořáková, H. & De Clercq, E. (1995) Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6. Antiviral. Res., 28, 343-357.
46. Sajjadi, F. G., Tabayashi, K., Foster, A. C., Domingo, R. C. & Firestein, G. S. (1996) Inhibition of TNF-α expression by adenosine: role of A3 adenosine receptors. J. Immunol., 156, 3435-3442.
47. Saville, M. W., Taga, K., Foli, A., Broder, S., Tosato, G. & Yarchoan, R. (1994) Interleukin-10 suppresses human immunodeficiency virus-1 replication in vitro in cells of the monocyte/macrophage lineage. Blood, 83, 3591-3599.
48. Srinivas, R. V., Robbins, B. L., Connelly, M. C., Gong, Y. -F., Bischofberger, N. & Fridland, A. (1993) Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonates. Antimicrob. Agents. Chemother., 37, 2247-2250.
49. Thormar, H., Georgsson, G., Palsson, P. A., Balzarini, J., Naesens, L., Torsteinsdottir, S., De Clercq, E. (1995) Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine on visna virus infection in lambs: a model for in vivo testing of candidate anti-human immunodeficiency virus drugs. Proc. natl. Acad. Sci. U.S.A., 92, 3283-3287.
50. Tsai, C. -C., Follis, K. E., Sabo, A., Beck, T. W., Grant, R. F., Bischofberger, N., Benveniste, R. E. & Black, R. (1995) Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine. Science, 270, 1197-1199.
51. Vahlenkamp, T. W., De Ronde, A., Balzarini, J., Naesens, L., De Clercq, E., van Eijk, M. J., Horzinek, M. C. & Egberink, H. F. (1995) (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection. Antimicrob. Agents. Chemother., 39, 746-749.
52. Villani, N., Calio, R., Balestra, E., Balzarini, J., De Clercq, E., Fabrizi, E., Perno, C. F. & Del Gobbo, V. (1994) 9-(2-phosphonylmethoxyethyl)adenine increases the survival of influenza virus-infected mice by an enhancement of the immune system. Antiviral Res., 25, 81-89.
53. Votruba, I., Trávníček, M., Rosenberg, I., Otmar, M., Merta, A., Hřebabecký, H. & Holý, A. (1990) Inhibition of avian myeloblastosis virus reverse transcriptase by diphosphates of acyclic phosphonylmethyl nucleotide analogues. Antiviral Res., 13, 287-293.
54. Yang, H. & Datema, R. (1991) Prolonged and potent therapeutic and phrophylactic effects of (S)-1-[(3-hydroxy-2-phosphonylmethoxy)propyl]-cytosine against herpes simplex virus type 2 infections in mice. Antimicrob. Agents. Chemother., 35, 1596-1600.
55. Zídek, Z., Holý, A. & Franková, D. (1997). Antiretroviral agent (R)-9-(2-phosphonomethoxypropyl)adenine stimulates cytokine and nitric oxide production. Eur. J. Pharmacol., 331, 245-252.